The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.
LEX Diagnostics receives US FDA 510(k) clearance and CLIA waiver for LEX VELO system: Cambridgeshire, UK Tuesday, February 17, 2026, 17:00 Hrs [IST] LEX Diagnostics, a leading inn ...
Ultra-fast point-of-care molecular diagnostics platform for key respiratory pathogens delivers results in under ten minutesCAMBRIDGESHIRE, UK, 16 February 2026 — LEX Diagnostics, a leading innovator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results